BWAY
$5.80
Brainsway Ltd ADR
($.24)
(3.97%)
BWAY
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.05)
Revenue:  $5.35 Mil
Monday
Nov 23
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BWAY reports earnings?
Beat
Meet
Miss

Where is BWAY's stock price going from here?
Up
Flat
Down
Stock chart of BWAY
Analysts
Summary of analysts' recommendations for BWAY
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. BrainsWay Ltd. is based in Jerusalem, Israel.